Solid Biosciences Inc.

SLDB · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$45,776-$39,480-$39,282-$42,597
Dep. & Amort.-$1,046-$488$407$488
Deferred Tax$0$0$0$0
Stock-Based Comp.$3,928$3,145$3,341$3,821
Change in WC$7,173-$2,539$1,793$2,129
Other Non-Cash$2,249$1,950$1,891$6,514
Operating Cash Flow-$33,472-$37,412-$31,850-$29,645
Investing Activities
PP&E Inv.-$85-$377-$126-$204
Net Acquisitions$0$0$0$0
Inv. Purchases-$83,188-$63,440-$65,337-$15,329
Inv. Sales/Matur.$38,000$31,000$38,000$54,100
Other Inv. Act.$0$85$0$0
Investing Cash Flow-$45,273-$32,732-$27,463$38,567
Financing Activities
Debt Repay.-$243-$142-$135-$128
Stock Issued$1,419-$1,655$189,883$6,857
Stock Repurch.$0$0-$20$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$196$0$211
Financing Cash Flow$1,176-$1,601$189,728$6,940
Forex Effect$0$0$0$0
Net Chg. in Cash-$77,569-$71,745$130,415$15,862
Supplemental Information
Beg. Cash$140,857$212,602$82,187$66,325
End Cash$63,288$140,857$212,602$82,187
Free Cash Flow-$33,557-$37,789-$31,976-$29,849